BioSpace News Archive

BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, announced the appointment of Corsee Sanders, Ph.D. to its Board of Directors and to the Audit and Scientific Advisory Committees of the Board.

The HPC storage solution ensures secure data access coupled with high performance. Since installing WekaFS, SIB supports a growing number of biomedical research projects.

Metacrine, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies to treat patients with liver and gastrointestinal diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track designation to MET409, the company’s lead farnesoid X receptor (FXR) agonist, for the treatment of non-alcoholic steatohepatitis (NASH). “We are very pleased that MET409 has rece

Mind Medicine Inc., the leading neuro-pharmaceutical company for psychedelic inspired medicines and the University Hospital Basel’s Liechti Lab are now combining MDMA and LSD in a groundbreaking Phase 1 clinical trial.

Not even six months after launching the antiviral treatment ViralOff®, it is getting what is best described as global coverage in media. Last week culminated in an appearance on, Good Morning America - How major fashion has joined the fight against COVID-19. That, however, is only the tip of the iceberg of attention we have receive

Sonnet BioTherapeutics Holdings, Inc. announced today that, as part of the previously announced warrant exchange agreement, all 3,300,066 Series A Warrants have been exercised at a price of $3.19 per share. Gross proceeds to the Company were $10.5 Million.

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the development and commercialization of prescription ophthalmic pharmaceuticals, today announces that Rick Eiswirth, President and Chief Executive Officer, will give a virtual corporate presentation at the LD Micro 500 taking place online on Wednesday, September 2, 2020 at 1:00 PM ET followed by a live Q&A session with registered investors and other conf

Albumins represent a group of acidic proteins, whose basic function is to regulate the colloidal osmotic pressure in the blood.

CRISPR-Cas systems are efficient and easily programmable nucleic acid-targeting tools, with usage expanding beyond research and therapeutic development to precision breeding of plants and animals and engineering of industrial microbes.

Ablation alludes to minimally invasive techniques which involve the surgical extraction of body tissues.